Compare Graham Holdings Company Common Stock (GHC) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Graham Holdings Company Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Graham Holdings Company Common Stock trades at $1,186.01 (market cap $4.97B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B). The key difference: Graham Holdings Company Common Stock is far larger — about 2.3× NeoGenomics Inc. Common Stock's market cap, and Graham Holdings Company Common Stock pays a 0.64% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| GHC | NEO | |
|---|---|---|
Market Cap | $4.97B | $2.14B |
Volume | 27,383 | 2,228,400 |
Sector | Industrials | Health |
52-Week High | $1.23K | $19.91 |
52-Week Low | $949.84 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.06B | $2.44B |
Dividend Yield | 0.64% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Graham Holdings Company Common Stock
Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.
Read more on GHC →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
